Trials / Recruiting
RecruitingNCT05700318
Study Using the ShiraTronics Migraine Therapy System
A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in Relieving, Interrupting, and Preventing Chronic Migraine
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- ShiraTronics · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to assess the preliminary safety and efficacy of the ShiraTronics Migraine Therapy System in prophylactic treatment of patients with refractory chronic migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | neurostimulator | The ShiraTronics Migraine Therapy System |
Timeline
- Start date
- 2023-05-05
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2023-01-26
- Last updated
- 2024-07-16
Locations
4 sites across 1 country: Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05700318. Inclusion in this directory is not an endorsement.